Overweight and Obesity Nutritional, Metabolic, Endocrine
Conditions
Interventions
Patients starting semaglutide once weekly self-administered injections for the treatment of overweight and obesity were invited to partake in the study. Participants were randomised to reveive their m
Sponsors
University Hospital Galway
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Starting semaglutide self-injection administration, for the first time and awaiting education 2. Capacity to give consent to being involved in the study 3. Judged to be capable to provide self-administration of injections by the human clinicians in the clinic- this will be determined in advance of being referred for education 4. There are no age limitations but patients will typically be over the age 18, as the research will take part in an Adult Outpatient Department Clinic. Inclusion will be based on an assessment of capacity rather than age
Exclusion criteria
Exclusion criteria: 1. Critically ill patients, who do not have capacity to consent or participate in the surveys due to their medical status (will be determined by the clinical care team) 2. While patients diagnosed with dementia or cognitive impairment will not be automatically excluded, participants must be able to give fully informed consent and can participate in completing the survey
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-Efficacy with injections, measured 2 weeks post-education session. Measured using "post" section of the validated "Self Injection Assessment Questionnaire" | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Knowledge of Semaglutide use- Custom-made 12 Question Test. Measured immediately after Education session- Day 0 2. Trust in the healthcare provider- Jian et al. Trust in Healthcare provider scale (modified). Measured immediately after Education session- Day 0 3. Consultation Satisfaction- Patients' Overall Satisfaction with Primary Care Physicians Scale (Modified). Measured immediately after Education session- Day 0 4. Usability.-Telehealth Usability Questionnaire (Modified)- Measured immediately after Education session- Day 0 | — |
Countries
Ireland
Contacts
Public ContactSean Coleman
Outcome results
None listed